Rising Costs, Price Pressure Usher In Uncertain Year Of The Rat In China
JPM Session Predicts Mixed Outlook
Executive Summary
Once the world's factory, China has seen costs inch up while drug prices are being cut deeply by centralized procurement schemes. As uncertainties mount, companies need to focus on improving process and scale-up technology, suggested industry observers at a JPM panel discussion on innovation and market access challenges.